Health ministry officials say plan to bring it under nation’s Universal Immunisation Programme stays shelved, mainly due to reasons related to funds and concern around side-effects.
Study conducted by Public Health Scotland in collaboration with University of Strathclyde & University of Edinburgh. Findings published in Journal of the National Cancer Institute.
Study by WHO's cancer research wing says incidence rates of cervical cancer a public health issue. Finds 39% cases occur in India & China, and is largely 'preventable' with HPV vaccine.
The CEO said that the production of India's 1st indigenously developed quadrivalent Human Papillomavirus (HPV) vaccine will supply 1 to 2 million doses per month to the govt.
Pune-based SII has got the go-ahead from the Drugs Controller General of India to market the vaccine. Cervical cancer is one of the leading causes of female cancer mortality worldwide.
Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.
HPV responsible for 95% of all cervical cancer. National Technical Advisory Group on Immunisation recommended HPV vaccine's inclusion in India's Universal Immunisation Programme in 2017.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
COMMENTS